346 related articles for article (PubMed ID: 8971091)
21. Lack of a role of neuronal nitric oxide synthase in the regulation of the renal function in rats fed a low-sodium diet.
Vanecková I; Kramer HJ; Malý J; Bäcker A; Bokemeyer D; Cervenka L
Kidney Blood Press Res; 2002; 25(4):224-31. PubMed ID: 12424424
[TBL] [Abstract][Full Text] [Related]
22. Disparate effects of castration on renal structure and function in the streptozotocin diabetic rat.
Bach LA; Cooper ME; Vranes D; Allen TJ; Rumble J; Jerums G
Diabetes Res; 1994; 27(1):27-38. PubMed ID: 7648794
[TBL] [Abstract][Full Text] [Related]
23. Low-protein diet and kidney function in insulin-dependent diabetic patients with diabetic nephropathy.
Hansen HP; Christensen PK; Tauber-Lassen E; Klausen A; Jensen BR; Parving HH
Kidney Int; 1999 Feb; 55(2):621-8. PubMed ID: 9987086
[TBL] [Abstract][Full Text] [Related]
24. The effects of perindopril and triple therapy in a normotensive model of diabetic nephropathy.
O'Brien RC; Cooper ME; Jerums G; Doyle AE
Diabetes; 1993 Apr; 42(4):604-9. PubMed ID: 8454112
[TBL] [Abstract][Full Text] [Related]
25. Characterization of the development of renal injury in Type-1 diabetic Dahl salt-sensitive rats.
Slaughter TN; Paige A; Spires D; Kojima N; Kyle PB; Garrett MR; Roman RJ; Williams JM
Am J Physiol Regul Integr Comp Physiol; 2013 Oct; 305(7):R727-34. PubMed ID: 23926133
[TBL] [Abstract][Full Text] [Related]
26. Sex-dependent differences in renal angiotensinogen as an early marker of diabetic nephropathy.
de Alencar Franco Costa D; Todiras M; Campos LA; Cipolla-Neto J; Bader M; Baltatu OC
Acta Physiol (Oxf); 2015 Mar; 213(3):740-6. PubMed ID: 25529203
[TBL] [Abstract][Full Text] [Related]
27. Tropisetron ameliorates early diabetic nephropathy in streptozotocin-induced diabetic rats.
Barzegar-Fallah A; Alimoradi H; Asadi F; Dehpour AR; Asgari M; Shafiei M
Clin Exp Pharmacol Physiol; 2015 Apr; 42(4):361-8. PubMed ID: 25676798
[TBL] [Abstract][Full Text] [Related]
28. Tight blood glycaemic and blood pressure control in experimental diabetic nephropathy reduces extracellular matrix production without regression of fibrosis.
Conway BR; Betz B; Sheldrake TA; Manning JR; Dunbar DR; Dobyns A; Hughes J; Mullins JJ
Nephrology (Carlton); 2014 Dec; 19(12):802-13. PubMed ID: 25196678
[TBL] [Abstract][Full Text] [Related]
29. The effect of an aldose reductase inhibitor (Epalrestat) on diabetic nephropathy in rats.
Itagaki I; Shimizu K; Kamanaka Y; Ebata K; Kikkawa R; Haneda M; Shigeta Y
Diabetes Res Clin Pract; 1994 Oct; 25(3):147-54. PubMed ID: 7851268
[TBL] [Abstract][Full Text] [Related]
30. Effects of p38 mitogen-activated protein kinase inhibition on blood pressure, renal hemodynamics, and renal vascular reactivity in normal and diabetic rats.
Komers R; Schutzer W; Xue H; Oyama TT; Lindsley JN; Anderson S
Transl Res; 2007 Dec; 150(6):343-9. PubMed ID: 18022596
[TBL] [Abstract][Full Text] [Related]
31. Aldosterone escape during blockade of the renin-angiotensin-aldosterone system in diabetic nephropathy is associated with enhanced decline in glomerular filtration rate.
Schjoedt KJ; Andersen S; Rossing P; Tarnow L; Parving HH
Diabetologia; 2004 Nov; 47(11):1936-9. PubMed ID: 15551047
[TBL] [Abstract][Full Text] [Related]
32. The salt paradox of the early diabetic kidney is independent of renal innervation.
Birk C; Richter K; Huang DY; Piesch C; Luippold G; Vallon V
Kidney Blood Press Res; 2003; 26(5-6):344-50. PubMed ID: 14610339
[TBL] [Abstract][Full Text] [Related]
33. Effects of SGLT2 inhibitor and dietary NaCl on glomerular hemodynamics assessed by micropuncture in diabetic rats.
Thomson SC; Vallon V
Am J Physiol Renal Physiol; 2021 May; 320(5):F761-F771. PubMed ID: 33645318
[TBL] [Abstract][Full Text] [Related]
34. Salt blocks the renal benefits of ramipril in diabetic hypertensive rats.
Fabris B; Jackson B; Johnston CI
Hypertension; 1991 Apr; 17(4):497-503. PubMed ID: 1826492
[TBL] [Abstract][Full Text] [Related]
35. Prevention of glomerular hyperfiltration in rats with streptozotocin-induced diabetes by an atrial natriuretic peptide receptor antagonist.
Sakamoto K; Kikkawa R; Haneda M; Shigeta Y
Diabetologia; 1995 May; 38(5):536-42. PubMed ID: 7489835
[TBL] [Abstract][Full Text] [Related]
36. Renal enlargement and insulin-like growth factor-1 accumulation in the Wistar rat model of experimental diabetes is not prevented by angiotensin converting enzyme inhibition.
New JP; Canavan JP; Flyvbjerg A; Hamon G; Bilous RW; Marshall SM
Diabetologia; 1996 Feb; 39(2):166-71. PubMed ID: 8635668
[TBL] [Abstract][Full Text] [Related]
37. Mechanisms of antioxidant and pro-oxidant effects of alpha-lipoic acid in the diabetic and nondiabetic kidney.
Bhatti F; Mankhey RW; Asico L; Quinn MT; Welch WJ; Maric C
Kidney Int; 2005 Apr; 67(4):1371-80. PubMed ID: 15780089
[TBL] [Abstract][Full Text] [Related]
38. Ornithine decarboxylase, kidney size, and the tubular hypothesis of glomerular hyperfiltration in experimental diabetes.
Thomson SC; Deng A; Bao D; Satriano J; Blantz RC; Vallon V
J Clin Invest; 2001 Jan; 107(2):217-24. PubMed ID: 11160138
[TBL] [Abstract][Full Text] [Related]
39. Chronic salt loading and cardiovascular-associated changes in experimental diabetes in rats.
Maeda C; Schaan B; Oliveira E; Oliveira V; De Angelis K; Irigoyen M
Clin Exp Pharmacol Physiol; 2007 Jul; 34(7):574-80. PubMed ID: 17581211
[TBL] [Abstract][Full Text] [Related]
40. Lovastatin preserves renal function in experimental diabetes.
Inman SR; Stowe NT; Cressman MD; Brouhard BH; Nally JV; Satoh S; Satodate R; Vidt DG
Am J Med Sci; 1999 Apr; 317(4):215-21. PubMed ID: 10210355
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
